178 related articles for article (PubMed ID: 17056532)
1. Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions.
Markel G; Seidman R; Stern N; Cohen-Sinai T; Izhaki O; Katz G; Besser M; Treves AJ; Blumberg RS; Loewenthal R; Mandelboim O; Orenstein A; Schachter J
J Immunol; 2006 Nov; 177(9):6062-71. PubMed ID: 17056532
[TBL] [Abstract][Full Text] [Related]
2. Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack.
Markel G; Seidman R; Cohen Y; Besser MJ; Sinai TC; Treves AJ; Orenstein A; Berger R; Schachter J
Immunology; 2009 Feb; 126(2):186-200. PubMed ID: 18557789
[TBL] [Abstract][Full Text] [Related]
3. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Ortenberg R; Sapir Y; Raz L; Hershkovitz L; Ben Arav A; Sapoznik S; Barshack I; Avivi C; Berkun Y; Besser MJ; Ben-Moshe T; Schachter J; Markel G
Mol Cancer Ther; 2012 Jun; 11(6):1300-10. PubMed ID: 22466331
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes.
Pandolfi F; Trentin L; Boyle LA; Stamenkovic I; Byers HR; Colvin RB; Kurnick JT
Cancer; 1992 Mar; 69(5):1165-73. PubMed ID: 1739916
[TBL] [Abstract][Full Text] [Related]
5. The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells.
Markel G; Gruda R; Achdout H; Katz G; Nechama M; Blumberg RS; Kammerer R; Zimmermann W; Mandelboim O
J Immunol; 2004 Sep; 173(6):3732-9. PubMed ID: 15356119
[TBL] [Abstract][Full Text] [Related]
6. The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitro.
Dupuis ML; Fiori V; Soriani A; Ricci B; Dominici S; Moricoli D; Ascione A; Santoni A; Magnani M; Cianfriglia M
J Immunother; 2015; 38(9):357-70. PubMed ID: 26448580
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
Stern N; Markel G; Arnon TI; Gruda R; Wong H; Gray-Owen SD; Mandelboim O
J Immunol; 2005 Jun; 174(11):6692-701. PubMed ID: 15905509
[TBL] [Abstract][Full Text] [Related]
8. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.
Rosenbaum SR; Tiago M; Caksa S; Capparelli C; Purwin TJ; Kumar G; Glasheen M; Pomante D; Kotas D; Chervoneva I; Aplin AE
Cell Rep; 2021 Dec; 37(10):110085. PubMed ID: 34879275
[TBL] [Abstract][Full Text] [Related]
9. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.
Topalian SL; Kasid A; Rosenberg SA
J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503
[TBL] [Abstract][Full Text] [Related]
10. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Ashkenazi S; Ortenberg R; Besser M; Schachter J; Markel G
Oncotarget; 2016 May; 7(21):30166-77. PubMed ID: 26885752
[TBL] [Abstract][Full Text] [Related]
11. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G
J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469
[TBL] [Abstract][Full Text] [Related]
14. CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival.
Ullrich N; Heinemann A; Nilewski E; Scheffrahn I; Klode J; Scherag A; Schadendorf D; Singer BB; Helfrich I
Cancer Res; 2015 May; 75(9):1897-907. PubMed ID: 25744717
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
[TBL] [Abstract][Full Text] [Related]
16. Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy.
Tran KQ; Zhou J; Durflinger KH; Langhan MM; Shelton TE; Wunderlich JR; Robbins PF; Rosenberg SA; Dudley ME
J Immunother; 2008 Oct; 31(8):742-51. PubMed ID: 18779745
[TBL] [Abstract][Full Text] [Related]
17. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
18. MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma.
Ullrich N; Löffek S; Horn S; Ennen M; Sánchez-Del-Campo L; Zhao F; Breitenbuecher F; Davidson I; Singer BB; Schadendorf D; Goding CR; Helfrich I
Pigment Cell Melanoma Res; 2015 Nov; 28(6):736-40. PubMed ID: 26301891
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions.
Gervois N; Guilloux Y; Diez E; Jotereau F
J Exp Med; 1996 May; 183(5):2403-7. PubMed ID: 8642353
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction.
Becker JC; Termeer C; Schmidt RE; Bröcker EB
J Immunol; 1993 Dec; 151(12):7224-32. PubMed ID: 7903103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
